SCHEMBL19496540

SCHEMBL19496540

CN1C(=O)c2ccccc2N(C)c2ncncc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK7 Q13164 8/20 0.49
▸ TTR P02766 2/20 0.49
▸ CES1 P23141 1/20 0.49
▸ LRRK2 Q5S007 6/20 0.48
▸ DCLK1 O15075 6/20 0.48
▸ PIK3CD O00329 3/20 0.47
▸ AURKA O14965 3/20 0.47
▸ PIK3C2G O75747 3/20 0.47
▸ PIK3CG P48736 3/20 0.47
▸ AURKB Q96GD4 3/20 0.47
▸ DRD2 P14416 1/20 0.44
▸ HTR6 P50406 1/20 0.44
▸ CASP3 P42574 1/20 0.42
▸ NUAK1 O60285 1/20 0.42
▸ BRD4 O60885 4/20 0.41
▸ BRDT Q58F21 1/20 0.41
▸ TRPA1 O75762 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ MTOR P42345 1/20 0.40
▸ RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29531391 1.00 MAPK7 (0.49) MAPK7TTRCES1LRRK2DCLK1
Hydrochloric Acid SCHEMBL29530065 0.98 MAPK7 (0.48) MAPK7TTRCES1LRRK2DCLK1
SCHEMBL29582820 0.84 DCLK1 (0.48) MAPK7TTRCES1LRRK2DCLK1
SCHEMBL16127516 0.78 TTR (0.75) TTRCES1LRRK2DRD2HTR6
SCHEMBL17721092 0.78 MAPK7 (0.57) MAPK7TTRCES1LRRK2DCLK1
SCHEMBL10098691 0.77 MAPK7 (0.56) MAPK7TTRCES1LRRK2DCLK1
SCHEMBL10098766 0.77 DCLK1 (0.58) MAPK7TTRCES1LRRK2DCLK1
SCHEMBL12059596 0.74 TTR (0.69) TTRCES1LRRK2DRD2HTR6
SCHEMBL29583687 0.74 CASP3 (0.40) MAPK7TTRCES1CASP3BRD4
SCHEMBL17519893 0.72 DCLK1 (0.78) MAPK7LRRK2DCLK1PIK3CDAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379559-B1 PYRIMIDO-DIAZEPINONE KINASE SCAFFOLD COMPOUNDS AND METHODS OF TREATING DISORDERS DANA FARBER CANCER INST INC (US) 2017-10-25 — — EP disclosed
Send feedback